FibroGen's GAAP loss for 6M 2021 was $206.066 million, up 25.9% from $163.661 million in the previous year. Revenue decreased 6.7% to $62.793 million from $67.288 million a year earlier.
FibroGen's GAAP loss for 6M 2021 was $206.066 million, up 25.9% from $163.661 million in the previous year. Revenue decreased 6.7% to $62.793 million from $67.288 million a year earlier. 
fibrogen.gcs-web.com
English (US) 